Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05156918 · ClinicalTrials.gov registry record · NA

The Effects of High-Intensity Exercise on Biological Age

A NA study, sponsored by Loma Linda University.

Completed
Registry status
NA
Development phase
35
Enrollment target

NCT05156918: Completed NA study, sponsored by Loma Linda University.

NCT05156918 is a NA study that has completed, run by Loma Linda University. The registered enrollment target is 35 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05156918, a NA study, has completed, sponsored by Loma Linda University.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target

Study Summary

The purpose of this graduate student research study is to determine if a high-intensity exercise program can slow or reverse biological (transcriptomic) aging and shed light on the underlying transcriptomic pathways involved.

Primary Outcome

Participants will have 8ml of blood drawn on two separate occasions by a certified phlebotomist. The first 8 ml (1.62tsp) blood draw will occur at 8am on day 1 of the study protocol. The second 8ml (1.62tsp) blood draw will occur approximately 30 days later. The total blood draw volume will be 16ml or approximately 3.25 teaspoons. The blood draw is to test for the effects of exercise on gene expression and aging.

Interventions

  • OTHER Exercise
  • OTHER Non Exercise

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2021-11-29
Est. Completion 2022-06-28
Phase NA
Loma Linda University

237 total trials

What the finished NCT05156918 record still lists

NCT05156918 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Exercise is the first listed.

NCT05156918 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05156918 about?

NCT05156918 is a clinical study titled "The Effects of High-Intensity Exercise on Biological Age". The purpose of this graduate student research study is to determine if a high-intensity exercise program can slow or reverse biological (transcriptomic) aging and shed light on the underlying transcriptomic pathways involved.

What is the current status of trial NCT05156918?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2021-11-29. Estimated completion is 2022-06-28.

What interventions are being tested in trial NCT05156918?

The interventions under investigation include: Exercise (OTHER), Non Exercise (OTHER).

Who is sponsoring clinical trial NCT05156918?

This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05156918's enrollment target sits among peer trials

35 1564th of 2000 higher than 431 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01697371 · 35 participants · NA

    Proton Therapy in the Treatment of Liver Metastases

  • NCT01940757 · 35 participants · Phase 1

    Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae

  • NCT02235857 · 35 participants · NA

    Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

  • NCT02637934 · 35 participants · Phase 1

    Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05156918, the US trial registry maintained by the National Library of Medicine. NCT05156918 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.